SUBSCRIBE
SUBSCRIBE
News   Drug Development

ARCA Discovery Inc. Gets Fast-Track Status for Heart Drug

November 24, 2009 | 
1 min read
Bookmark and Share

Reuters -- ARCA biopharma Inc said U.S. health regulators granted a fast-track designation for its experimental drug, Gencaro, to treat chronic heart failure, sending its shares up as much as 81 percent.
Clinical research Phase 2
MORE ON THIS TOPIC
Insights
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
February 12, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Viral vector, gene therapy, DNA delivery. Virus inserting genetic material into a cell nucleus. Gene editing, therapeutic genes, engineering, genetic diseases, dna, CRISPR, biotechnology. Medicine 3D illustration
Gene therapy
In Vivo Is Having a Moment as Cell and Gene Therapy Sector Gathers in San Diego
February 11, 2026
 · 
4 min read
 · 
Heather McKenzie
Close-up of back skin with urticaria
Immunology and inflammation
Nektar’s Rezpeg Differentiates in Atopic Dermatitis With Durable, Deep Responses in Mid-Stage
February 11, 2026
 · 
2 min read
 · 
Tristan Manalac
Syringe and a vial above the map of the USA. Illustration of the concept of the vaccination and immunization in the United States
Vaccines
FDA Refuses To Review Moderna’s mRNA Flu Vaccine, Claims Trial Inadequacies
February 11, 2026
 · 
4 min read
 · 
Tristan Manalac